Lubiprostone in Patients With Multiple Sclerosis Associated Constipation

Summary

The purpose of the study is to assess how safe and effective the drug Lubiprostone is in people with Multiple Sclerosis (MS)and moderate to severe MS-associated constipation. Lubiprostone is approved by the FDA for the treatment of two common types of constipation in adults, chronic idiopathic constipation and irritable bowel syndrome.

Timeline

Start

2010-11

Primary completion

2012-01

Completion

2012-04

Drugs

Indications